News & Updates
Filter by Specialty:

Oral minocycline flops for geographic atrophy in AMD
01 Apr 2024
Treatment with oral minocycline falls short of slowing the rate of geographic atrophy (GA) enlargement in patients with age-related macular degeneration (AMD), according to the results of a phase II study.
Oral minocycline flops for geographic atrophy in AMD
01 Apr 2024
Response to first-line treatment tied to longer survival in HER2-positive breast cancer
30 Mar 2024
Patients with de novo human epidermal growth receptor 2 (HER2)-positive metastatic breast cancer (MBC) who show radiographic response to first-line HER2-directed therapy are more likely to achieve long-term survival, suggests a recent study.
Response to first-line treatment tied to longer survival in HER2-positive breast cancer
30 Mar 2024
SBRT as effective as Y90 for HCC, but cheaper
29 Mar 2024
Use of either stereotactic body radiotherapy (SBRT) or yttrium-90 (Y90) is effective in the management of hepatocellular carcinoma (HCC), resulting in similar overall and progression-free survival, reports a study. However, Y90 is more expensive than SBRT.